|
Markt geschlossen -
CBOE
17:30:00 11.09.2026
|
Perf. 5 T | Veränd. 1. Jan. | ||
| 3.217 EUR | 0.00% |
|
0.00% | -40.37% |
| 09.09. | Evotec startet Phase-1-Studie für potenzielle Behandlung gegen Pocken und Mpox | MT |
| 09.09. | Evotec startet klinische Frühphasenstudie zu potenzieller Orthopoxvirus-Therapie | MT |
Hauptkonkurrenten
| Dividendenrendite (Y) | Dividendenrendite (Y+1) | KGV (Y) | Price to Book (Y) | EV / Umsatz (Y) | Marktkap. / EBITDA (Y) | Marktkap. / EBIT (Y) | Marktkap.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 1.05% | 1.21% | 31.04x | 4.15x | 5.6x | 16.76x | 23.45x | 45.48 Mrd. | ||
| -.--% | -.--% | -20.85x | 21.54x | 240.83x | -22.36x | -21.1x | 43.68 Mrd. | ||
| -.--% | -.--% | 33.71x | 6.16x | 3.27x | 14.1x | 21.31x | 43.09 Mrd. | ||
| -.--% | -.--% | 45.39x | 7.68x | 5.23x | 28.64x | 32.96x | 39.4 Mrd. | ||
| 0.42% | 0.47% | 27.03x | 2.19x | 8.15x | 20.66x | 24.53x | 31.91 Mrd. | ||
| -.--% | -.--% | 33.41x | 23.97x | 5.47x | 24.85x | 26x | 16.4 Mrd. | ||
| 1.13% | 1.28% | 23.57x | 2.62x | 2.06x | 8.94x | 13.85x | 14.24 Mrd. | ||
| -.--% | -.--% | 74.44x | 4.41x | 3.94x | 15.27x | 18.75x | 13.28 Mrd. | ||
| -.--% | -.--% | 28.74x | 1.36x | 1.89x | 11.62x | 13.23x | 13.06 Mrd. | ||
| 0.44% | 0.44% | 52.2x | 4.55x | 8.66x | 24.58x | 29.32x | 11.31 Mrd. | ||
| -.--% | -.--% | -42.37x | 21.24x | 7.06x | 172.31x | -1563.24x | 10.65 Mrd. | ||
| -.--% | -.--% | -28.56x | 8.41x | 110.17x | -28.99x | -47.94x | 10.25 Mrd. | ||
| 0.6% | 0.75% | 37.13x | 4.27x | 4.39x | 18.79x | 30.21x | 10.13 Mrd. | ||
| -.--% | -.--% | 31.86x | - | 16.69x | 30.46x | 29.75x | 9.59 Mrd. | ||
| -.--% | -.--% | -29.69x | 8.63x | 78.41x | -19.77x | -19.17x | 9.56 Mrd. | ||
| -.--% | -.--% | -24.09x | 8.32x | 10026.59x | -19.8x | -19.5x | 9.34 Mrd. | ||
| -.--% | -.--% | -344.99x | 2.26x | 10.15x | 60.28x | 78.87x | 9.02 Mrd. | ||
| -.--% | -.--% | -14.92x | 627.58x | 9.76x | -15.66x | -15.11x | 9.01 Mrd. | ||
| Durchschnitt | 0.2% | 0.23% | -4.83x | 44.67x | 586.02x | 18.93x | -74.66x | 19.41 Mrd. | |
| Nach Marktkapitalisierung gewichteter Durchschnitt | 0.25% | 0.29% | 10.37x | 25.06x | 308.18x | 15.45x | -33.81x |
- Börse
- Aktien
- 566480 Aktie
- 566480 Aktie
- Sektor Evotec SE
- branchenspezifische Dividenden
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
















